197 related articles for article (PubMed ID: 35442555)
1. SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway.
Li C; Wang M; Shi Y; Xin H
Environ Toxicol; 2022 Aug; 37(8):1934-1943. PubMed ID: 35442555
[TBL] [Abstract][Full Text] [Related]
2. DACT3 has a tumor-inhibiting role in acute myeloid leukemia via the suppression of Wnt/β-catenin signaling by DVL2.
Gao Q; Hou L; Wang H; Xun L
J Biochem Mol Toxicol; 2022 May; 36(5):e23014. PubMed ID: 35187752
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.
Zhai H; Zhao J; Pu J; Zhao P; Wei J
Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643
[TBL] [Abstract][Full Text] [Related]
4. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
Li C; Xin H; Shi Y; Mu J
Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
7. Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway.
Xi HM; Lu H; Weng XQ; Sheng Y; Wu J; Li L; Cai X
Anticancer Agents Med Chem; 2023; 23(9):1074-1084. PubMed ID: 36627782
[TBL] [Abstract][Full Text] [Related]
8. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
Clausen KA; Blish KR; Birse CE; Triplette MA; Kute TE; Russell GB; D'Agostino RB; Miller LD; Torti FM; Torti SV
Breast Cancer Res Treat; 2011 Oct; 129(3):737-46. PubMed ID: 21113658
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
[TBL] [Abstract][Full Text] [Related]
10. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway.
Xin H; Li C; Wang M
Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373
[TBL] [Abstract][Full Text] [Related]
11. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
Xiao Y; Deng T; Ming X; Xu J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
[TBL] [Abstract][Full Text] [Related]
12. miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting Axin2 and modulating the Wnt/β-catenin pathway.
Liu Z; Zhong L; Dan W; Chu X; Liu C; Luo X; Zhang Z; Lu Y; Wan P; Wang X; Liu B
Biochem Biophys Res Commun; 2022 Sep; 620():83-91. PubMed ID: 35780585
[TBL] [Abstract][Full Text] [Related]
13. SOX30 confers a tumor suppressive effect in acute myeloid leukemia through inactivation of Wnt/β-catenin signaling.
Liu Y; Wang W; Li Y; Huang Y
Mol Cell Probes; 2020 Aug; 52():101578. PubMed ID: 32334007
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-301b-3p induces proliferation and inhibits apoptosis in AML cells by targeting FOXF2 and regulating Wnt/β-catenin axis.
Lu Y; Zhong L; Luo X; Liu C; Dan W; Chu X; Wan P; Zhang Z; Wang X; Liu Z; Liu B
Mol Cell Probes; 2022 Jun; 63():101805. PubMed ID: 35259424
[TBL] [Abstract][Full Text] [Related]
16. Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells.
Almars A; Chondrou PS; Onyido EK; Almozyan S; Seedhouse C; Babaei-Jadidi R; Nateri AS
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167387
[TBL] [Abstract][Full Text] [Related]
17. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
Wang Y; Tong H; Wang J; Hu L; Huang Z
J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.
Gandillet A; Park S; Lassailly F; Griessinger E; Vargaftig J; Filby A; Lister TA; Bonnet D
Leukemia; 2011 May; 25(5):770-780. PubMed ID: 21339756
[TBL] [Abstract][Full Text] [Related]
19. A novel dipeptide type inhibitor of the Wnt/β-catenin pathway suppresses proliferation of acute myelogenous leukemia cells.
Wakabayashi R; Hattori Y; Hosogi S; Toda Y; Takata K; Ashihara E
Biochem Biophys Res Commun; 2021 Jan; 535():73-79. PubMed ID: 33341676
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological targeting of type phosphodiesterase 4 inhibits the development of acute myeloid leukemia by impairing mitochondrial function through the Wnt/β-catenin pathway.
Mao P; Huang C; Li Y; Zhao Y; Zhou S; Zhao Z; Mu Y; Wang L; Li F; Zhao AZ
Biomed Pharmacother; 2023 Jan; 157():114027. PubMed ID: 36436494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
